4.1 Article

Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients

Related references

Note: Only part of the references are listed.
Article Biochemical Research Methods

Comparison of proteomic biomarker panels in urine and serum for ovarian cancer diagnosis

Anette Lykke Petri et al.

PROTEOMICS CLINICAL APPLICATIONS (2010)

Article Biochemical Research Methods

Discovery and identification of potential biomarkers of pediatric Acute Lymphoblastic Leukemia

Linan Shi et al.

PROTEOME SCIENCE (2009)

Article Medical Laboratory Technology

Mass spectrometry-based hepcidin measurements in serum and urine: Analytical aspects and clinical implications

Erwin H. J. M. Kemna et al.

CLINICAL CHEMISTRY (2007)

Article Oncology

Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients

CC Earle et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)

Article Biochemical Research Methods

Characterization of serum biomarkers for detection of early stage ovarian cancer

KR Kozak et al.

PROTEOMICS (2005)

Review Oncology

Biomarkers of ovarian tumours

AV Rapkiewicz et al.

EUROPEAN JOURNAL OF CANCER (2004)

Article Oncology

Prognostic significance of p53, Her-2, and EGFR overexpression in borderline and epithelial ovarian cancer

JS Nielsen et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2004)

Article Multidisciplinary Sciences

Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: Potential use in diagnosis and prognosis

KR Kozak et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Biochemical Research Methods

A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease

O Carrette et al.

PROTEOMICS (2003)

Article Obstetrics & Gynecology

Survival and prognostic factors in patients with ovarian cancer

S Tingulstad et al.

OBSTETRICS AND GYNECOLOGY (2003)

Article Medicine, General & Internal

Use of proteomic patterns in serum to identify ovarian cancer

EF Petricoin et al.

LANCET (2002)